Charles Schwab
TRAW icon

Charles Schwab’s Traws Pharma TRAW Stock Holding History

Charles Schwab’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-284
Closed -$107K – 3550
2021
Q1 		$107K Buy
+284
New +$107K ﹤0.01% 3377
2014
Q2 		– Hold
0
– -$84K – 3145
2014
Q1 		– Hold
0
– – – 3045
2013
Q4 		– Hold
0
– – – 3022
2013
Q3 		– Hold
0
– – – 2710

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Charles Schwab's TRAW Position: Q2 2021 in Review

Charles Schwab sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 284 shares — an estimated $107K sold.

Charles Schwab first reported a position in TRAW in Q1 2021 and held it in 1 quarter. The position peaked at $107K in Q1 2021. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

  • Charles Schwab reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
  • Charles Schwab sold 284 Traws Pharma shares in Q2 2021, an estimated $107K.
  • Charles Schwab first reported a position in Traws Pharma in Q1 2021 and held it in 1 quarter.
  • Charles Schwab's Traws Pharma position peaked at $107K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.